Ghrelin expression of endometrium hyperplasia and endometrioid carcinoma


Dagli A. F., Aydin S., Kocdor H., Gurates B., Sahin I., Catak Z., ...More

GYNECOLOGICAL ENDOCRINOLOGY, vol.27, no.3, pp.199-204, 2011 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3
  • Publication Date: 2011
  • Doi Number: 10.3109/09513590.2010.488772
  • Journal Name: GYNECOLOGICAL ENDOCRINOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.199-204
  • Erzincan Binali Yildirim University Affiliated: Yes

Abstract

Background. Endometrium carcinoma ranks fourth among female carcinomas. Therefore, early diagnosis of endometrium pre-malignant lesions is emphasised, and attempts are made to identify the risk factors. Since hyperplasias, particularly those with atypia, are held responsible for the development of the most common endometrium carcinomas, it is important to definitely distinguish between well-differentiated carcinomas and hyperplasia with atypia. In the present study, we aimed to explore whether ghrelin expression had a role in distinguishing between benign, pre-malignant and malignant lesions of endometrium.